ConductScience.org, home

Paper475374

Human fibroblast interferon for clinical trials: production, partial purification, and characterization.

Billiau A and 7 others. Antimicrob Agents Chemother, 1979. Cited by 51 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Human fibroblast interferon for clinical trials: production, partial purification, and characterization. Papers, record 475374. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475374

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human fibroblast interferon for clinical trials: production, partial purification, and characterization.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.7
iCite
Revised in PubMed
2021-05-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Billiau AA
2Damme JVJ V
3Leuven FVF V
4Edy VGV G
5De Ley MM
6Cassiman JJJ J
7Van de Berghe HH
8De Somer PP

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibroblastsMajor topic
InterferonsMajor topic
Cells, Cultured
Diploidy
Humans
Immunoelectrophoresis

Source PubMed

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,729Large-scale production of human leukocyte interferon containing 10(8) units per ml.J Gen Virol1978https://conductscience.org/library/papers/26729PubMed
282,514Uptake and degradation of alpha2-macroglobulin-protease complexes in human cells in culture.Exp Cell Res1978https://conductscience.org/library/papers/82514PubMed
371,999Demonstration of alpha2-macroglobulin in cultured fibroblasts, using crossed immunoelectrophoresis.Exp Cell Res1977https://conductscience.org/library/papers/71999PubMed
496,117Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin.J Biol Chem1978https://conductscience.org/library/papers/96117PubMed
5342,973Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns.Nature1978https://conductscience.org/library/papers/342973PubMed
6291,364Transformation-sensitive cell surface protein: isolation, characterization, and role in cellular morphology and adhesion.Ann N Y Acad Sci1978https://conductscience.org/library/papers/291364PubMed
7649,623The impossibility of defining unequivocally the antiviral activity of human fibroblast interferon in terms of a human leukocyte interferon standard.J Biol Stand1978https://conductscience.org/library/papers/649623PubMed
8883,813Human interferon: mass production in a newly established cell line, MG-63.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/883813PubMed
91,036,458Purification of interferon by adsorption chromatography on controlled pore glass.J Gen Virol1976https://conductscience.org/library/papers/1036458PubMed
104,360,630Mass production of human interferon in diploid cells stimulated by poly-I:C.J Gen Virol1973https://conductscience.org/library/papers/4360630PubMed
11239,056Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons.J Immunol1975https://conductscience.org/library/papers/239056PubMed
1253,841Multiple active sites on human interferons.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/53841PubMed
134,471,020Mass production of human interferon in diploid cells.In Vitro Monogr1974https://conductscience.org/library/papers/4471020PubMed
14180,244Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection.J Gen Virol1976https://conductscience.org/library/papers/180244PubMed
15164,521Distinct molecular species of human interferons: requirements for stabilzation and reactivation of human leukocyte and fibroblast interferons.J Gen Virol1975https://conductscience.org/library/papers/164521PubMed
164,670,440Production of high-titered interferon in cultures of human diploid cells.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4670440PubMed
171,061,154Interferon: purification and initial characterization from human diploid cells.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1061154PubMed
181,185,850Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.J Virol1975https://conductscience.org/library/papers/1185850PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
35,140,938Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide.Clin Transl Immunology2022https://conductscience.org/library/papers/35140938PubMed
33,563,543Interferons and other cytokines, genetics and beyond in COVID-19 and autoimmunity.Cytokine Growth Factor Rev2021https://conductscience.org/library/papers/33563543PubMed
32,694,927Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case.Mediators Inflamm2020https://conductscience.org/library/papers/32694927PubMed
6,400,034The clinical application of fibroblast interferon--an overview.Med Oncol Tumor Pharmacother1984https://conductscience.org/library/papers/6400034PubMed
6,167,863Comparative antiviral efficiency of leukocyte and bacterially produced human alpha-interferon in rhesus monkeys.Nature1981https://conductscience.org/library/papers/6167863PubMed
6,166,278Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.Arch Virol1981https://conductscience.org/library/papers/6166278PubMed
6,163,417Interferon therapy: pharmacokinetic and pharmacological aspects.Arch Virol1981https://conductscience.org/library/papers/6163417PubMed
2,379,114The induction and characterization of natural porcine interferons alpha and beta.Can J Vet Res1990https://conductscience.org/library/papers/2379114PubMed
475,375Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/475375PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
FN12,335PubTator's text mininghttps://conductscience.org/library/genes/2335

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/475374

GET https://conductscience.org/api/papers/v1/475374/authors